Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Observation of Treatment Patterns With Lucentis in Approved Indications
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)
- Status
- COMPLETED
- Phase
- PHASE2
Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE1
Urticaria Facticia Treatment With Omalizumab (UFO)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD
- Status
- COMPLETED
- Phase
- PHASE4
OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE3
Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery
- Status
- COMPLETED
- Phase
- PHASE2